All In Biotech

Free tool

FAERS Monitor: Gamifant

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761107 or its brand name (Gamifant, Emapalumab-Lzsg). Reports on generic versions are filed under their own applications.

Reports

237

Serious

209

88% of reports

Hospitalization

67

Death reported

106

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use94
  • haemophagocytic lymphohistiocytosis72
  • condition aggravated60
  • drug ineffective32
  • death29
  • septic shock21
  • epstein-barr virus infection14
  • multiple organ dysfunction syndrome14
  • adenovirus infection13
  • hypertension13
  • pyrexia13
  • serum ferritin increased12
  • still^s disease10
  • respiratory failure9
  • sepsis9

Reports by year received

View as table
YearReports
201917
202015
202112
202218
202318
202431
202562
202664

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,922 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
haemophagocytic lymphohistiocytosisSignal72859.7708.060,336
adenovirus infectionSignal13399.6235.34,757
serum ferritin increasedSignal12202.4116.52,203
epstein-barr virus infectionSignal14199.3119.82,563
multiple organ dysfunction syndromeSignal1443.926.4545
septic shockSignal2142.928.5818
condition aggravatedSignal6017.514.1931
respiratory failureSignal911.05.872
off label useSignal949.58.1740
sepsisSignal97.23.842
hypertensionSignal135.43.243
pyrexiaSignal133.32.019
deathSignal293.02.138
drug ineffectiveSignal322.21.620
still^s disease100.00.0801,736

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.